Project Details
Description
To study the effect of the orphan drug, 3,4 Diaminopyridine (3,4 DAP), on hereditary demyelinating neuropathies. 3,4 DAP is a potassium channel blocking agent which has been demonstrated to improve conduction in demyelinated nerve fibers in experimental models.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/92 → 9/30/95 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.